December 22, 2021

Around the nation: FDA grants approval for the first injectable HIV prevention treatment

Daily Briefing

    FDA on Monday approved the first injectable treatment for HIV prevention, in today's bite-sized hospital and health industry news from the District of Columbia, Maryland, and Tennessee.

    • District of Columbia: Mayor Muriel Bowser on Monday declared a state of emergency and issued multiple Covid-19 prevention measures, including an indoor mask mandate and a booster shot requirement for city employees. The indoor mask mandate went into effect on Monday and will last until Jan. 31. "[W]e have to respond to what's happening in our city and what's happening in our nation," Bowser said. In addition, Bowser announced expanded testing measures in the city. And while a negative Covid-19 test will not be required for students to return to school after winter break, all D.C. public schools will be closed on Jan. 3 and 4 to allow students, families, and staff to pick up free rapid tests. (Hopkins, Axios, 12/20)
    • Maryland: FDA on Monday approved Apretude, an injectable treatment for HIV pre-exposure prevention (PrEP) that reduces the risk of HIV transmission. The agency conducted two trials that evaluated the drug's safety and efficacy. In the first trial, the drug reduced the risk of HIV infection among cisgender men and transgender women by 69% compared to a daily oral medication. In the second trial, risk of infection decreased by 90% among cisgender women. "This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S., including helping high-risk individuals and certain groups where adherence to daily medication has been a major challenge or not a realistic option," said Debra Birnkrant, director of the division of antivirals in the FDA's Center for Drug Evaluation and Research. (Falconer, Axios, 12/20)
    • Tennessee: HCA Healthcare on Monday announced that Todd Jackson was appointed CEO of Twin Cities Hospital in the health system's North Florida Division. Jackson succeeds Dave Whalen, who had led the hospital since 1987. Jackson, who has held multiple leadership roles with the health system over the last 15 years, most recently served as market COO for Fort Walton Beach Medical Center and Twin Cities Hospital. (Jensik, Becker's Hospital Review, 12/20)

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.